CAPTRUST Financial Advisors
RCUS icon

CAPTRUST Financial Advisors’s Arcus Biosciences RCUS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,072
Closed -$53K – 3594
2022
Q2 		$53K Buy
2,072
+1,660
+403% +$40.7K ﹤0.01% 2706
2022
Q1 		$13K Sell
412
-73
-15% -$2.45K ﹤0.01% 3665
2021
Q4 		$20K Buy
485
+149
+44% +$5.78K ﹤0.01% 3287
2021
Q3 		$12K Buy
336
+13
+4% +$405 ﹤0.01% 3505
2021
Q2 		$9K Sell
323
-13
-4% -$371 ﹤0.01% 3610
2021
Q1 		$9K Sell
336
-398
-54% -$13.8K ﹤0.01% 3495
2020
Q4 		$19K Buy
+734
New +$17.8K ﹤0.01% 2277

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CAPTRUST Financial Advisors's RCUS Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Arcus Biosciences (RCUS) in Q3 2022, closing a stake of 2,072 shares — an estimated $53K sold.

CAPTRUST Financial Advisors first reported a position in RCUS in Q4 2020 and held it in 7 quarters. The position peaked at $53K in Q2 2022. 184 funds tracked by Wall St. Rank hold RCUS as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Arcus Biosciences position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,072 Arcus Biosciences shares in Q3 2022, an estimated $53K.
  • CAPTRUST Financial Advisors first reported a position in Arcus Biosciences in Q4 2020 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Arcus Biosciences position peaked at $53K in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.